Notice2023-18635
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Service Satisfaction Surveys
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 30, 2023
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 167 (Wednesday, August 30, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 167 (Wednesday, August 30, 2023)]
[Notices]
[Page 59928]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18635]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-1053]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Customer/Partner
Service Satisfaction Surveys
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments (including recommendations) on the
collection of information by September 29, 2023.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to <a href="https://www.reginfo.gov/public/do/PRAMain">https://www.reginfo.gov/public/do/PRAMain</a>. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0360. Also include the FDA docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
<a href="/cdn-cgi/l/email-protection#da8a889b89aebbbcbc9abcbebbf4b2b2a9f4bdb5ac"><span class="__cf_email__" data-cfemail="77272536240316111137111316591f1f0459101801">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Customer/Partner Service Satisfaction Surveys
OMB Control Number 0910-0360--Extension
Under section 1003 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 393), FDA is authorized to conduct research and public
information programs about regulated products and responsibilities of
the Agency. Executive Order 12862, entitled ``Setting Customer Service
Standard,'' directs Federal Agencies that ``provide significant
services directly to the public'' to ``survey customers to determine
the kind and quality of services they want and their level of
satisfaction with existing services.'' FDA is seeking to extend OMB
approval to conduct customer service satisfaction surveys to implement
Executive Order 12862. Participation in the surveys is voluntary. This
request covers customer/partner (including State and local governments)
service satisfaction surveys of regulated entities, such as food
processors; cosmetic, drug, biologic, and medical device manufacturers;
animal drugs, animal food and feed; tobacco products; and consumers and
health professionals.
FDA will use the information from these surveys to identify
strengths and weaknesses in service to customers/partners and to make
improvements. The surveys will measure timeliness, appropriateness,
clarity, and accuracy of information, courtesy, and problem resolution
in the context of individual programs.
FDA estimates conducting approximately 20 customer/partner service
satisfaction surveys per year, each requiring an average of 25 minutes
for review and completion. We estimate respondents to these surveys to
be between 100 and 20,000 customers/partners. Some of these surveys
will be repeats of earlier surveys for purposes of monitoring customer/
partner service and developing long-term data. Respondents to this
collection of information cover a broad range of stakeholders who have
experience with certain products regulated by or services provided by
FDA.
In the Federal Register of April 25, 2023 (88 FR 24992), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. One comment was received in support of this
information collection.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Mail, telephone, web-based survey........ 85,000 1 85,000 0.42 (25 minutes)............................ 35,700
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Since the last OMB approval of this information collection request,
FDA submitted three requests to increase the total burden hours.
Therefore, this request for extension of OMB approval adjusts the
number of respondents by an increase of 30,000 and the total burden
hours by an increase of 21,950.
Dated: August 24, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-18635 Filed 8-29-23; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 30, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.